CLINICAL_TRIALS
trial_result
· 2018-03-22
Clinical Trial Update: Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders [Phase 4]
Summary
Phase 4 trial of sertraline for social phobia with co-occurring anxiety and mood disorders has been terminated. The study examined sertraline across comorbid co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hamilton Health Sciences Corporation | Conditions: Phobia, Social, Panic Disorder | Phase 4 | Status: TERMINATED